The MAP Kinases and Their Role in Mast Cells and Basophils

  • Cheng Zhang
  • Michael A. Beaven
Chapter

Abstract

The available information on the relationships of mitogen-activated protein (MAP) kinases to mast cell function, and more so on the relationship to FcεRI-mediated function, is insufficient for meaningful review. However, meaningful scenarios can be discussed when comparisons are made with cells that have features in common with the mast cell and with other multimeric immune receptors that employ similar signaling systems to FcεRI. In this review, we provide an overview of the MAP kinases and then discuss their activation in lymphocytes and blood granulocytes before discussion of the mast cell. We have chosen for comparison with the mast cell, T and B lymphocytes, eosinophils and neutrophils because these cells express multimeric immune receptors and share some of the features of mast cells.

Keywords

Lipase Dexamethasone Rapamycin Threonine Erythropoietin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fureder W, Agis H, Willheim M, et al. Differential expression of complement receptors on human basophils and mast cells: evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995;155:3152–3160.PubMedGoogle Scholar
  2. 2.
    Smith TJ, Weis JH. Mucosal T cells and mast cells share common adhesion receptors. Trends Immunol 1996;17:60–63.Google Scholar
  3. 3.
    Beaven MA, Baumgartner RA. Downstream signals initiated in mast cells by FcεRI and other receptors. Curr Opin Immunol 1996;8:766–772.PubMedGoogle Scholar
  4. 4.
    Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179–185.PubMedGoogle Scholar
  5. 5.
    Campbell JS, Seger R, Graves J, et al. The MAP kinase cascade. Recent Prog Horm Res 1995;50:131–159.PubMedGoogle Scholar
  6. 6.
    Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996;49:1187–1198.PubMedGoogle Scholar
  7. 7.
    Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995;270:12665–12669.PubMedGoogle Scholar
  8. 8.
    Abe J, Kusuhara M, Ulevitch RJ, et al. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 1996;271:16586–16590.PubMedGoogle Scholar
  9. 9.
    Ferrell JE. Tripping the switch fantastic: how a protein kinase can convert graded inputs into switch-like outputs. Trends Biochem Sci 1996;21:460–466.PubMedGoogle Scholar
  10. 10.
    Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995;20:117–122.PubMedGoogle Scholar
  11. 11.
    Fukunaga R, Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 1997;16:1921–1933.PubMedGoogle Scholar
  12. 12.
    Waskiewicz AJ, Flynn A, Proud CG, et al. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997;16:1909–1920.PubMedGoogle Scholar
  13. 13.
    Ludwig S, Engel K, Hoffmeyer A, et al. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 1996;16:6687–6697.PubMedGoogle Scholar
  14. 14.
    Jiang Y, Li Z, Schwarz EM, et al. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J Biol Chem 1997;272:11096–11102.PubMedGoogle Scholar
  15. 15.
    Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995;80:225–236.PubMedGoogle Scholar
  16. 16.
    L’Allemain G. Deciphering the MAP kinase pathway. Prog Growth Factor Res 1994;5:291–334.PubMedGoogle Scholar
  17. 17.
    Keyse SM. An emerging family of dual specificity MAP kinase phosphatases. Biochim Biophys Acta 1995;1265:152–160.PubMedGoogle Scholar
  18. 18.
    Karin M, Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 1995;5:747–757.PubMedGoogle Scholar
  19. 19.
    Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 1996;318:729–747.PubMedGoogle Scholar
  20. 20.
    Ahn NG, Weiel JE, Chan CP, et al. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J Biol Chem 1990;265:11487–11494.PubMedGoogle Scholar
  21. 21.
    Rossomando AJ, Payne DM, Weber MJ, et al. Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/ threonine protein kinase. Proc Natl Acad Sci USA 1989;86:6940–6943.PubMedGoogle Scholar
  22. 22.
    Miyasaka T, Chao MV, Sherline P, et al. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2. J Biol Chem 1990;265:4730–4735.PubMedGoogle Scholar
  23. 23.
    Lin LL, Wartmann M, Lin AY, et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269–278.PubMedGoogle Scholar
  24. 24.
    Sturgill TW, Ray LB, Erikson E, et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature (Lond) 1988;334:715–718.Google Scholar
  25. 25.
    Takishima K, Griswold-Prenner I, Ingebritsen T, et al. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3–l1 cells is an EGF-stimulated “MAP” kinase. Proc Natl Acad Sci USA 1991;88:2520–2524.PubMedGoogle Scholar
  26. 26.
    Gille H, Kortenjann M, Thomae O, et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995;14:951–962.PubMedGoogle Scholar
  27. 27.
    Schlaepfer DD, Hunter T. Signal transduction from the extracellular matrix—a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct Funct 1996;21:445–450.PubMedGoogle Scholar
  28. 28.
    Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025–1037.PubMedGoogle Scholar
  29. 29.
    Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313–24316.PubMedGoogle Scholar
  30. 30.
    Rivera J, Beaven MA. Role of protein kinase C isozymes in secretion. In: Parker P, Dekker L, eds. Protein Kinase C. (Molecular Biology Intelligence Unit Series.) Austin, TX: RG Landes, 1997:131–164.Google Scholar
  31. 31.
    Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 1995;83:1–4.PubMedGoogle Scholar
  32. 32.
    van Biesen T, Hawes BE, Luttrell DK, et al. Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway. Nature (Lond) 1995;376:781–784.Google Scholar
  33. 33.
    Touhara K, Hawes BE, van Biesen T, et al. G protein βγ subunits stimulate phosphorylation of She adapter protein. Proc Natl Acad Sci USA 1995;92:9284–9287.PubMedGoogle Scholar
  34. 34.
    Winston LA, Hunter T. Intracellular signalling: putting JAKs on the kinase MAP. Curr Biol 1996;6:668–671.PubMedGoogle Scholar
  35. 35.
    Burack WR, Sturgill TW. The activating dual phosphorylation of MAPK by MEK is non-processive. Biochemistry 1997;36:5929–5933.PubMedGoogle Scholar
  36. 36.
    Zhang F, Strand A, Robbins D, et al. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature (Lond) 1994;367:704–711.Google Scholar
  37. 37.
    Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995;270:14843–14846.PubMedGoogle Scholar
  38. 38.
    Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726–735.PubMedGoogle Scholar
  39. 39.
    Kouhara H, Hadari YR, Spivak-Kroizman T, et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/ MAPK signaling pathway. Cell 1997;89:693–702.PubMedGoogle Scholar
  40. 40.
    Batzer AG, Rotin D, Urena JM, et al. Hierarchy of binding sites for Grb2 and She on the epidermal growth factor receptor. Mol Cell Biol 1994;14:5192–5201.PubMedGoogle Scholar
  41. 41.
    Skolnik EY, Batzer A, Li N, et al. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 1993;260:1953–1955.PubMedGoogle Scholar
  42. 42.
    Katzav S, Martin-Zanca D, Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 1989;8:2283–2290.PubMedGoogle Scholar
  43. 43.
    Collins TL, Deckert M, Altman A. Views on Vav. Immunol Today 1997;18:221–225.PubMedGoogle Scholar
  44. 44.
    Gulbins E, Coggeshall KM, Baier G, et al. Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol 1994;14:4749–4758.PubMedGoogle Scholar
  45. 45.
    Tocque B, Delumeau I, Parker F, et al. Ras-GTPase activating protein (GAP): a putative effector for Ras. Cell Signal 1997;9:153–158.PubMedGoogle Scholar
  46. 46.
    van Dijk MCM, Muriana FJG, de Widt J, et al. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in rat-1 fibro-blasts. J Biol Chem 1997;272:11011–11016.PubMedGoogle Scholar
  47. 47.
    Cowen DS, Sowers RS, Manning DR. Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptaminelA receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J Biol Chem 1996;271:22297–22300.PubMedGoogle Scholar
  48. 48.
    Grammer TC, Blenis J. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 1997;14:1635–1642.PubMedGoogle Scholar
  49. 49.
    Hawes BE, van Biesen T, Koch WJ, et al. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 1995;270:17148–17153.PubMedGoogle Scholar
  50. 50.
    van Biesen T, Hawes BE, Raymond JR, et al. G0-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem 1996;271:1266–1269.PubMedGoogle Scholar
  51. 51.
    Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond) 1994;369:156–160.Google Scholar
  52. 52.
    Sluss HK, Barrett T, Derijard B, et al. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994; 14:8376–8384.PubMedGoogle Scholar
  53. 53.
    Su B, Jacinto E, Hibi M, et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994;77:727–736.PubMedGoogle Scholar
  54. 54.
    Yan M, Dai T, Deak JC, et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature (Lond) 1994;372:798–800.Google Scholar
  55. 55.
    Minden A, Lin A, McMahon M, et al. Differential activation of ERK and JNK mitogenactivated protein kinases by Raf-1 and MEKK. Science 1994;266:1719–1723.PubMedGoogle Scholar
  56. 56.
    Lin A, Minden A, Martinetto H, et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995;268:286–290.PubMedGoogle Scholar
  57. 57.
    Minden A, Lin A, Claret FX, et al. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995;81:1147–1157.PubMedGoogle Scholar
  58. 58.
    Coso OA, Chiariello M, Yu JC, et al. The small GTP-binding proteins Racl and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995;81:1137–1146.PubMedGoogle Scholar
  59. 59.
    Lopez-Ilasaca M, Li W, Uren A, et al. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. Biochem Biophys Res Commun 1997;232:273–277.PubMedGoogle Scholar
  60. 60.
    Crespo P, Schuebel KE, Ostrom AA, et al. Phosphotyrosine-dependent activation of Rac1 GDP/GTP exchange by the vav protooncogene product. Nature (Lond) 1997;385:169–172.Google Scholar
  61. 61.
    Teramoto H, Salem P, Robbins KC, et al. Tyrosine phosphorylation of the vav protooncogene product links FcεRI to the Rac1-JNK pathway. J Biol Chem 1997;272:10751–10755.PubMedGoogle Scholar
  62. 62.
    Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994;78:1027–1037.PubMedGoogle Scholar
  63. 63.
    Han J, Lee JD, Bibbs L, et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808–811.PubMedGoogle Scholar
  64. 64.
    Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond) 1994;372:739–746.Google Scholar
  65. 65.
    Zervos AS, Faccio L, Gatto JP, et al. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 1995;92:10531–10534.PubMedGoogle Scholar
  66. 66.
    Jiang Y, Chen C, Li Z, et al. Characterization of the structure and function of a new mitogenactivated protein kinase (p38β). J Biol Chem 1996;271:17920–17926.PubMedGoogle Scholar
  67. 67.
    Li Z, Jiang Y, Ulevitch RJ, et al. The primary structure of p38γ: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996;228:334–340.PubMedGoogle Scholar
  68. 68.
    Wang Z, Harkins PC, Ulevitch RJ, et al. The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution. Proc Natl Acad Sci USA 1997;94:2327–2332.PubMedGoogle Scholar
  69. 69.
    Wilson KP, Fitzgibbon MJ, Caron PR, et al. Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 1996;271:27696–27700.PubMedGoogle Scholar
  70. 70.
    Derijard B, Raingeaud J, Barrett T, et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995;267:682–685.PubMedGoogle Scholar
  71. 71.
    Robinson MJ, Cheng M, Khokhlatchev A, et al. Contributions of the mitogen-activated protein (MAP) kinase backbone and phosphorylation loop to MEK specificity. J Biol Chem 1996;271:29734–29739.PubMedGoogle Scholar
  72. 72.
    Brunei A, Pouyssegur J. Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science 1996;272:1652–1655.Google Scholar
  73. 73.
    Minden A, Lin A, Smeal T, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994;14:6683–6688.PubMedGoogle Scholar
  74. 74.
    David M, Petricoin E III, Benjamin C, et al. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 1995;269:1721–1723.PubMedGoogle Scholar
  75. 75.
    Freshney NW, Rawlinson L, Guesdon F, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994;78:1039–1049.PubMedGoogle Scholar
  76. 76.
    Kolch W, Heidecker G, Kochs G, et al. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature (Lond) 1993;364:249–252.Google Scholar
  77. 77.
    Enslen H, Tokumitsu H, Stork PJS, et al. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci USA 1996;93:10803–10808.PubMedGoogle Scholar
  78. 78.
    Ueda Y, Hirai SI, Osada SI, et al. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1996;271:23512–23519.PubMedGoogle Scholar
  79. 79.
    Ahmed S, Lee J, Kozma R, et al. A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin. J Biol Chem 1993;268:10709–10712.PubMedGoogle Scholar
  80. 80.
    Dudley DT, Pang L, Decker SJ, et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686–7689.PubMedGoogle Scholar
  81. 81.
    Alessi DR, Cuenda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489–27494.PubMedGoogle Scholar
  82. 82.
    Pang L, Sawada T, Decker SJ, et al. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995;270:13585–13588.PubMedGoogle Scholar
  83. 83.
    Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94:448–452.PubMedGoogle Scholar
  84. 84.
    Lee JC, Adams JL. Inhibitors of serine/threonine kinases. Curr Opin Biotechnol 1995;6:657–661.PubMedGoogle Scholar
  85. 85.
    Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229–233.PubMedGoogle Scholar
  86. 86.
    McLaughlin MM, Kumar S, McDonnell PC, et al. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 1996;271:8488–8492.PubMedGoogle Scholar
  87. 87.
    Beyaert R, Cuenda A, Vanden Berghe W, et al. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 1996;15:1914–1923.PubMedGoogle Scholar
  88. 88.
    Young PR, McLaughlin MM, Kumari S, et al. Pyridinyl imidazole inhibitors of p38 mitogenactivated protein kinase bind in the ATP site. J Biol Chem 1997;272:12116–12121.PubMedGoogle Scholar
  89. 89.
    Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996;271:6586–6589.PubMedGoogle Scholar
  90. 90.
    Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 1995;92:12230–12234.PubMedGoogle Scholar
  91. 91.
    Badger AM, Bradbeer JN, Votta B, et al. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996;279:1453–1461.PubMedGoogle Scholar
  92. 92.
    Welham MJ, Duronio V, Schrader JW. Interleukin-4-dependent proliferation dissociates p44erk-l, p42erk-2, and p21ras activation from cell growth. J Biol Chem 1994;269:5865–5873.PubMedGoogle Scholar
  93. 93.
    Franklin RA, Tordai A, Patel H, et al. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J Clin Invest 1994;93:2134–2140.PubMedGoogle Scholar
  94. 94.
    Alberola-Ila J, Forbush KA, Segar R, et al. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (Lond) 1995;373:620–623.Google Scholar
  95. 95.
    Sen J, Kapeller R, Fragoso R, et al. Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J Immunol 1996;156:4535–4538.PubMedGoogle Scholar
  96. 96.
    Levin SD, Anderson SJ, Forbush KA, et al. A dominant-negative transgene defines a role for p561ck in thymopoiesis. EMBO J 1993;12:1671–1680.PubMedGoogle Scholar
  97. 97.
    Li W, Whaley CD, Mondino A, et al. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 1996;271:1272–1276.PubMedGoogle Scholar
  98. 98.
    Fields PE, Gajewski TF, Fitch FW. Blocked Ras activation in anergic CD4+ T cells. Science 1996;271:1276–1278.PubMedGoogle Scholar
  99. 99.
    Gulbins E, Coggeshall KM, Baier G, et al. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 1993;260:822–825.PubMedGoogle Scholar
  100. 100.
    Gupta S, Weiss A, Kumar G, et al. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem 1994;269:17349–17357.PubMedGoogle Scholar
  101. 101.
    Downward J, Graves JD, Warne PH, et al. Stimulation of p21ras upon T-cell activation. Nature (Lond) 1990;346:719–723.Google Scholar
  102. 102.
    Tordai A, Franklin RA, Patel H, et al. Cross-linking of surface IgM stimulates the Ras/ Raf-1/MEK/MAPK cascade in human B lymphocytes. J Biol Chem 1994;269:7538–7543.PubMedGoogle Scholar
  103. 103.
    Franklin RA, Brodie C, Melamed I, et al. Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytes. J Immunol 1995;154:4965–4972.PubMedGoogle Scholar
  104. 104.
    Sutherland CL, Health AW, Pelech SL, et al. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol 1996;157:3381–3390.PubMedGoogle Scholar
  105. 105.
    Kashiwada M, Kaneko Y, Yagita H, et al. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells. Eur J Immunol 1996;26:1451–1458.PubMedGoogle Scholar
  106. 106.
    Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326–1331.PubMedGoogle Scholar
  107. 107.
    Gulbins E, Langlet C, Baier G, et al. Tyrosine phosphorylation and activation of Vav GTP/ GDP exchange activity in antigen receptor-triggered B cells. J Immunol 1994;152:2123–2129.PubMedGoogle Scholar
  108. 108.
    Gold MR, Crowley MT, Martin G, et al. Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins. J Immunol 1993;150:377–386.PubMedGoogle Scholar
  109. 109.
    Lazarus AH, Kawauchi K, Rapoport MJ, et al. Antigen-induced B lymphocyte activation involves the p21ras and ras-GAP signaling pathway. J Exp Med 1993;178:1765–1769.PubMedGoogle Scholar
  110. 110.
    Kumar G, Wang S, Gupta S, et al. The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line. Biochem J 1995;307:215–223.PubMedGoogle Scholar
  111. 111.
    Hallett MB, Lloyds D. Neutrophil priming: the cellular signals that say “amber” but not “green”. Immunol Today 1995;16:264–268.PubMedGoogle Scholar
  112. 112.
    El Benna J, Han J, Park JW, et al. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch Biochem Biophys 1996;334:395–400.PubMedGoogle Scholar
  113. 113.
    Grinstein S, Furuya W. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J Biol Chem 1992;267:18122–18125.PubMedGoogle Scholar
  114. 114.
    Thompson HL, Marshall CJ, Saklatvala J. Characterization of two different forms of mitogen-activated protein kinase kinase induced in polymorphonuclear leukocytes following stimulation by N-formylmethionylleucyl-phenylalanine or granulocyte-macrophage colony-stimulating factor. J Biol Chem 1994;269:9486–9492.PubMedGoogle Scholar
  115. 115.
    Torres M, Hall FL, O’Neill K. Stimulation of human neutrophils with formyl-methionylleucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol 1993;150:1563–1577.PubMedGoogle Scholar
  116. 116.
    Pillinger MH, Feoktistov AS, Capodici C, et al. Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion. J Biol Chem 1996;271:12049–12056.PubMedGoogle Scholar
  117. 117.
    Worthen GS, Avdi N, Buhl AM, et al. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. J Clin Invest 1994;94:815–823.PubMedGoogle Scholar
  118. 118.
    Obel D, Rasmussen LH, Christiansen NO. Protein kinase C subtypes in human neutrophils. Scand J Clin Lab Invest 1991;51:299–302.PubMedGoogle Scholar
  119. 119.
    Waterman WH, Molski TF, Huang CK, et al. Tumour necrosis factor-α-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem J 1996;319:17–20.PubMedGoogle Scholar
  120. 120.
    Yu H, Suchard SJ, Nairn R, et al. Dissociation of mitogen-activated protein kinase activation from the oxidative burst in differentiated HL-60 cells and human neutrophils. J Biol Chem 1995;270:15719–15724.PubMedGoogle Scholar
  121. 121.
    el Benna J, Faust LP, Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem 1994;269:23431–23436.PubMedGoogle Scholar
  122. 122.
    Waterman WH, Sha’afi RI. Effects of granulocyte-macrophage colony-stimulating factor and tumour necrosis factor-α on tyrosine phosphorylation and activation of mitogen-activated protein kinases in human neutrophils. Biochem J 1995;307:39–45.PubMedGoogle Scholar
  123. 123.
    Nick JA, Avdi NJ, Gerwins P, et al. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J Immunol 1996;156:4867–4875.PubMedGoogle Scholar
  124. 124.
    Fouda SI, Molski TF, Ashour MS, et al. Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. Biochem J 1995;308:815–822.PubMedGoogle Scholar
  125. 125.
    Nahas N, Waterman WH, Sha’afi RI. Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes phosphorylation and an increase in the activity of cytosolic Phospholipase A2 in human neutrophils. Biochem J 1996;313:503–508.PubMedGoogle Scholar
  126. 126.
    Pazdrak K, Schreiber D, Forsythe P, et al. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995;181:1827–1834.PubMedGoogle Scholar
  127. 127.
    Bates ME, Bertics PJ, Busse WW. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 1996;156:711–718.PubMedGoogle Scholar
  128. 128.
    Pazdrak K, Stafford S, Alam R. The activation of the Jak-STAT1 signaling pathway by IL-5 in eosinophils. J Immunol 1995;155:397–402.PubMedGoogle Scholar
  129. 129.
    Pazdrak K, Justement L, Alam R. Mechanism of inhibition of eosinophil activation by trans- forming growth factor-β. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 1995;155:4454–4458.PubMedGoogle Scholar
  130. 130.
    Araki R, Komada T, Nakatani K, et al. Protein kinase C-independent activation of Raf-1 and mitogen-activated protein kinase by leukotriene B4 in guinea pig eosinophils. Biochem Biophys Res Commun 1995;210:837–843.PubMedGoogle Scholar
  131. 131.
    O’Flaherty JT, Kuroki M, Nixon AB, et al. 5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes. J Immunol 1996;157:336–342.PubMedGoogle Scholar
  132. 132.
    Suchard SJ, Mansfield PJ, Boxer LA, et al. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide. J Immunol 1997;158:4961–4967.PubMedGoogle Scholar
  133. 133.
    Offermanns S, Jones SVP, Bombien E, et al. Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J Immunol 1994;152:250–261.PubMedGoogle Scholar
  134. 134.
    Santini F, Beaven MA. Tyrosine phosphorylation of a mitogen activated protein (MAP) kinase-like protein occurs at a late step in exocytosis: studies with tyrosine phosphatase inhibitors and various secretagogues in RBL-2H3 cells. J Biol Chem 1993;268:22716–22722.PubMedGoogle Scholar
  135. 135.
    Hirasawa N, Santini F, Beaven MA. Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line: indications of different pathways for release of arachidonic acid and secretory granules. J Immunol 1995;154:5391–5402.PubMedGoogle Scholar
  136. 136.
    Hirasawa N, Scharenberg A, Yamamura H, et al. A requirement for Syk in the activation of the MAP kinase/phospholipase A2 pathway by FcεRI is not shared by a G protein-coupled receptor. J Biol Chem 1995;270:10960–10967.PubMedGoogle Scholar
  137. 137.
    Zhang C, Baumgartner RA, Yamada K, et al. Mitogen activated protein (MAP) kinase regulates production of TNF-α and release of arachidonic acid in mast cells: indications of communication between p38 and p42 MAP kinases. J Biol Chem 1997;272:13397–13402.PubMedGoogle Scholar
  138. 138.
    Zhang C, Hirasawa N, Beaven MA. Antigen activation of mitogen-activated protein kinase in mast cells through protein kinase C dependent and independent pathways. J Immunol 1997;158:4968–4975.PubMedGoogle Scholar
  139. 139.
    Fukamachi H, Takei M, Kawakami T. Activation of multiple protein kinases including a MAP kinase upon FcεRI cross-linking. Int Arch Allergy Immunol 1993;102:15–25.PubMedGoogle Scholar
  140. 140.
    Ishizuka T, Oshiba A, Sakata N, et al. Aggregation of the FcεRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin. J Biol Chem 1996;271:12762–12766.PubMedGoogle Scholar
  141. 141.
    Ishizuka T, Terada N, Gerwins P, et al. Mast cell tumor necrosis factor-α production is regulated by MEK kinases. Proc Natl Acad Sci USA 1997;94:6358–6363.PubMedGoogle Scholar
  142. 142.
    Tsai M, Chen RH, Tarn SY, et al. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcεRI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol 1993;23:3286–3291.PubMedGoogle Scholar
  143. 143.
    Kawakami Y, Miura T, Bissonnette R, et al. Bruton’s tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 1997;94:3939–3942.Google Scholar
  144. 144.
    Serve H, Yee NS, Stella G, et al. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J 1995;14:473–483.PubMedGoogle Scholar
  145. 145.
    Margolis B, Hu P, Katzav S, et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature (Lond) 1992;356:71–74.Google Scholar
  146. 146.
    Cuenod B, Zhang C, Scharenberg AM, et al. Syk-dependent phosphorylation of She: a potential link between FcεRI and the Ras/MAP kinase signaling pathway through Sos and Grb2. J Biol Chem 1996;271:16268–16272.Google Scholar
  147. 147.
    Scharenberg AM, Lin S, Cuenod B, et al. Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. EMBO J 1995;14:3385–3394.PubMedGoogle Scholar
  148. 148.
    Zhang J, Berenstein EH, Evans RL, et al. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 1996;184:71–80.PubMedGoogle Scholar
  149. 149.
    Song JS, Gomez J, Stancato LF, et al. Association of a p95 Vav-containing signaling complex with the FcεRI chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1 and ERK2 in an active complex. J Biol Chem 1996 271:26962–26970.PubMedGoogle Scholar
  150. 150.
    Murakami M, Austen KF, Arm JP. The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. J Exp Med 1995;182:197–206.PubMedGoogle Scholar
  151. 151.
    Paulson RF, Vesely S, Siminovitch KA, et al. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 1996;13:309–315.PubMedGoogle Scholar
  152. 152.
    Kinashi T, Escobedo JA, Williams LT, et al. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase Cγ 1 pathways. Blood 1995;86:2086–2090.PubMedGoogle Scholar
  153. 153.
    Kawakami Y, Yao L, Miura T, et al. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking. Mol Cell Biol 1994;14:5108–5113.PubMedGoogle Scholar
  154. 154.
    Rawlings DJ, Scharenberg AM, Park H, et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 1996;271:822–825.PubMedGoogle Scholar
  155. 155.
    Mahajan S, Fargnoli J, Burkhardt AL, et al. Src family protein tyrosine kinases induce autoactivation of Bruton’s tyrosine kinase. Mol Cell Biol 1995;15:5304–5311.PubMedGoogle Scholar
  156. 156.
    Park H, Wahl MI, Afar DE, et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 1996;4:515–525.PubMedGoogle Scholar
  157. 157.
    Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton’s tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 1994;91:9175–9179.PubMedGoogle Scholar
  158. 158.
    Tolias KF, Cantley LC, Carpenter CL. Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 1995;270:17656–17659.PubMedGoogle Scholar
  159. 159.
    Rider LG, Hirasawa N, Santini F, et al. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 1996;157:2374–2380.PubMedGoogle Scholar
  160. 160.
    Ozawa K, Szallasi Z, Kazanietz MG, et al. Ca2+- dependent and Ca2+-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells: reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J Biol Chem 1993;268:1749–1756.PubMedGoogle Scholar
  161. 161.
    Glover S, de Carvalho MS, et al. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 1995;270:15359–15367.PubMedGoogle Scholar
  162. 162.
    Ishimoto T, Arisato K, Akiba S, et al. Requirement of calcium influx for hydrolytic action of membrane phospholipids by cytosolic phospholipase A2 rather than mitogen-activated protein kinase activation in FcεRI-stimulated rat peritoneal mast cells. J Biochem (Tokyo) 1996;120:1247–1252.Google Scholar
  163. 163.
    Lin P, Wiggan GA, Gilfillan AM. Activation of phospholipase D in a rat mast (RBL-2H3) cell line: a possible unifying mechanism for IgE-dependent degranulation and arachidonic acid metabolite release. J Immunol 1991;146:1609–1616.PubMedGoogle Scholar
  164. 164.
    Koike T, Mizutani T, Hirai K, et al. SCF/c-kit receptor-mediated arachidonic acid liberation in rat mast cells. Involvement of PLD activation associated tyrosine phosphorylation. Biochem Biophys Res Commun 1993;197:1570–1577.PubMedGoogle Scholar
  165. 165.
    Ishimoto T, Akiba S, Sato T, et al. Contribution of phospholipases A2 and D to arachidonic acid liberation and prostaglandin D2 formation with increase in intracellular Ca2+ concentration in rat peritoneal mast cells. Eur J Biochem 1994;219:401–406.PubMedGoogle Scholar
  166. 166.
    Murakami M, Kudo I, Umeda M, et al. Detection of three distinct phospholipases A2 in cultured mast cells. J Biochem (Tokyo) 1992;111:175–181.Google Scholar
  167. 167.
    Borsch-Haubold AG, Kramer RM, Watson SP. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem J 1996;318:207–212.PubMedGoogle Scholar
  168. 168.
    Kramer RM, Roberts EF, Urn SL, et al. P38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid release by cPLA2. J Biol Chem 1996;271:27723–27729.PubMedGoogle Scholar
  169. 169.
    Prieschl EE, Gouilleux V, Walker C, et al. A nuclear factor of activated T cell-like transcription factor in mast cells is involved in IL-5 gene regulation after IgE plus antigen stimulation. J Immunol 1995;154:6112–6119.PubMedGoogle Scholar
  170. 170.
    Prieschl EE, Pendl GG, Harrer NE, et al. P21ras links FcεRI to NF-AT family member in mast cells. The AP3-like factor in this cell type is an NF-AT family member. J Immunol 1995;155:4963–4970.PubMedGoogle Scholar
  171. 171.
    Reimann T, Buscher D, Hipskind RA, et al. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1β and the TNF-α genes. J Immunol 1994;153:5740–5749.PubMedGoogle Scholar
  172. 172.
    Li S, Sedivy JM. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc Natl Acad Sci USA 1993;90:9247–9251.PubMedGoogle Scholar
  173. 173.
    Park JH, Levitt L. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-κB. Blood 1993;82:2470–2477.PubMedGoogle Scholar
  174. 174.
    Baumgartner RA, Beaven MA. Mediator release by mast cells and basophils. In: Herzenberg LA, Herzenberg L, Weir DM, Blackwell C, eds. Weir’s Handbook of Experimental Immunology, vol. 4.5th Ed. Cambridge: Blackwell, 1996:213.1–213.8.Google Scholar
  175. 175.
    Galli SJ. New concepts about the mast cell. New Engl J Med 1993;328:257–265.PubMedGoogle Scholar
  176. 176.
    Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458–464.PubMedGoogle Scholar
  177. 177.
    Galli SJ, Wershil BK. The two faces of the mast cell. Nature (Lond) 1996;381:21–22.Google Scholar
  178. 178.
    Baumgartner RA, Yamada K, Deramo VA, et al. Secretion of tumor necrosis factor (TNF) from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process. J Immunol 1994;153:2609–2617.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1999

Authors and Affiliations

  • Cheng Zhang
  • Michael A. Beaven

There are no affiliations available

Personalised recommendations